drugset / Trial / NCT03635125

Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine

NCT03635125

RandomizedParallel-groupOpen-labelHealth-services research

Summary

Study is to evaluate the effect of Nebivolol to treat high blood pressure compared to an already approved drug, Metoprolol ER with background treatment of Amlodipine.

Timeline

Start
2010-08-30
Primary completion
2011-05-26
Completion
2011-07-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified 50 mg
Comparator Metoprolol Other / unclassified 100 mg
Comparator Nebivolol Other / unclassified 10 mg
Comparator Nebivolol Other / unclassified 20 mg

Indications

No indication recorded.